SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-20-012065
Filing Date
2020-12-16
Accepted
2020-12-16 11:30:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27647
2 filename2.txt TEXT-EXTRACT 1478
  Complete submission text file 0000000000-20-012065.txt   40367
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Filed for) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)